IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 fourth quarter and full year financial results for Monday, February 2, 2026 ...

Good morning, and welcome to the IDEXX Laboratories Third Quarter 2025 Earnings Conference Call. As a reminder, today's conference is being recorded. Participating in the call this morning are Jay ...

In the latest quarter, 4 analysts provided ratings for IDEXX Laboratories (NASDAQ:IDXX), showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, ...

IDEXX Laboratories IDXX has shown remarkable momentum, rallying 64.7% in the last 12 months. The stock has comfortably surpassed the industry’s 2.8% growth and the S&P 500 Composite’s 17.7% gain.

IDEXX Laboratories on Tuesday named insider Michael Erickson as its next chief executive officer and said incumbent Jonathan Mazelsky will retire in 2027. The appointment will be effective May 12, at ...

Ratings for IDEXX Laboratories (NASDAQ:IDXX) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview ...

IDEXX Laboratories is a leader in animal diagnostics, boasting strong recurring revenue and nearly 50% stock gains year-to-date. IDXX's innovation pipeline, robust cash position, and global reach ...

Idexx Laboratories has steadily increased its scale and reach in the veterinary diagnostic lab business to dig a narrow moat. It is well-positioned to benefit from two key trends. First, pet ownership ...

Idexx Laboratories has steadily increased its scale and reach in the veterinary diagnostic lab business to dig a narrow moat. It is well-positioned to benefit from two key trends. First, pet ownership ...